Alkermes Plc (ALKS)
47.12
-0.08
(-0.17%)
USD |
NASDAQ |
Sep 02, 13:43
Alkermes Net Income (TTM) : 66.12M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.12M |
| March 31, 2026 | 152.72M |
| December 31, 2025 | 241.66M |
| September 30, 2025 | 338.06M |
| June 30, 2025 | 348.09M |
| March 31, 2025 | 355.65M |
| December 31, 2024 | 372.14M |
| September 30, 2024 | 386.95M |
| June 30, 2024 | 341.92M |
| March 31, 2024 | 484.32M |
| December 31, 2023 | 433.32M |
| September 30, 2023 | 289.95M |
| June 30, 2023 | 178.22M |
| March 31, 2023 | -88.98M |
| December 31, 2022 | -112.84M |
| September 30, 2022 | -129.14M |
| June 30, 2022 | -94.15M |
| March 31, 2022 | -61.65M |
| December 31, 2021 | -48.17M |
| September 30, 2021 | -91.68M |
| June 30, 2021 | -62.83M |
| March 31, 2021 | -94.62M |
| December 31, 2020 | -110.86M |
| September 30, 2020 | -73.57M |
| June 30, 2020 | -126.32M |
| Date | Value |
|---|---|
| March 31, 2020 | -138.88M |
| December 31, 2019 | -196.62M |
| September 30, 2019 | -200.98M |
| June 30, 2019 | -182.54M |
| March 31, 2019 | -173.20M |
| December 31, 2018 | -139.31M |
| September 30, 2018 | -139.39M |
| June 30, 2018 | -141.22M |
| March 31, 2018 | -151.57M |
| December 31, 2017 | -157.94M |
| September 30, 2017 | -169.30M |
| June 30, 2017 | -195.71M |
| March 31, 2017 | -199.90M |
| December 31, 2016 | -208.44M |
| September 30, 2016 | -256.68M |
| June 30, 2016 | -275.01M |
| March 31, 2016 | -273.93M |
| December 31, 2015 | -227.16M |
| September 30, 2015 | -127.27M |
| June 30, 2015 | -86.21M |
| March 31, 2015 | -36.36M |
| December 31, 2014 | -30.06M |
| September 30, 2014 | -42.50M |
| June 30, 2014 | -10.30M |
| March 31, 2014 | -6.705M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Amarin Corp. Plc | -27.07M |
| Jazz Pharmaceuticals Plc | 940.76M |
| Prothena Corp. Plc | -43.99M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Biogen, Inc. | 834.60M |